Breast Cancer Post Market Monitoring of Drugs & Procurement Strategies
Clicks: 1
ID: 309257
2024
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
1 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #145 of 153 articles by views in International Journal of Pharmaceutical Drug Design (IJPDD)
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 153 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Breast cancer represents a formidable global health challenge, necessitating continual advancements in treatment modalities and healthcare delivery. This research paper explores the pivotal intersection of post-market monitoring of breast cancer drugs and strategic procurement strategies, aiming to optimize patient outcomes while ensuring accessibility and affordability. Beginning with an overview of the current landscape, this paper investigates the methodologies and regulatory frameworks governing post-market monitoring breast cancer drugs. It scrutinizes the strengths and limitations of existing surveillance mechanisms, including spontaneous reporting systems and real-world evidence generation, and examines emerging trends such as Pharmacovigilance in digital health platforms. This paper delves into the complexities of drug procurement, analyzing various strategies employed by healthcare systems and stakeholders to enhance accessibility and affordability
| Reference Key |
imported_1761930143_6904eb9f463c2
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Neelam Dhankar |
| Journal | International Journal of Pharmaceutical Drug Design (IJPDD) |
| Year | 2024 |
| DOI |
DOI not found
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.